Share this post on:

Product Name :
Aspacytarabine

Search keywords :
Cytarabine

drugId :
null

Target Vo:
DNA-directed DNA polymerase

Target Vo Short Name :
DNA-directed DNA polymerase

Moa_Name:
DNA-directed DNA polymerase inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Biosight Ltd

Active Company_Name :
Biosight Ltd

Active Indication_Name:
Myelodysplastic Syndromes

In Active Indication_Name:
Precursor Cell Lymphoblastic Leukemia-Lymphoma

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PARP1 Antibody (YA245)
OGT Antibody
FIP200 Antibody: FIP200 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 183 kDa, targeting to FIP200. It can be used for WB assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Interleukin Related